NASDAQ Composite ended the session with Amgen jumping 2.4% to $245.38 on Monday while nASDAQ Composite fell 0.48% to $13,895.12.
Amgen today’s close was $245.38, 12.76% below its 52-week high of $276.69.
Amgen’s sales growth is 3.6% for the present quarter and 5% for the next. The company’s growth estimates for the current quarter and the next is a negative 4.2% and a negative 1.6%, respectively.
Year-on-year quarterly revenue growth declined by 4.2%, now sitting on 25.16B for the twelve trailing months.
Amgen’s Stock Yearly Top and Bottom Value
Amgen’s stock is valued at $245.38 at 17:08 EST, way under its 52-week high of $276.69 and way higher than its 52-week low of $207.33.
Amgen’s Moving Average
Amgen’s worth is above its 50-day moving average of $236.56 and higher than its 200-day moving average of $235.37.
More news about Amgen.